Two COVID-19 antivirals get FDA nod for emergency use
Unlike in the case of remdesivir, both the drugs — Pfizer’s paxlovid and Merck’s molnupiravir — are oral pills and
Read More
Antiviral
Restrictive voluntary license of COVID-19 antivirals compromises access, says Leena Menghaney
In an email, Leena Menghaney, South Asia Head of Médecins Sans Frontières’s Access Campaign, says that the voluntary license will
Read More
Pfizer’s antiviral Paxlovid is a major advancement potentially for all coronaviruses, says Gagandeep Kang
In an email, Dr. Gagandeep Kang, Professor of Microbiology at CMC Vellore explains the significance of paxlovid antiviral for treatment,
Read More
Zydus Cadila’s antiviral drug for moderate COVID-19 disease gets emergency use approval
“A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered
Read More